Marksans Pharma Ltd
company logo

Marksans Pharma Ltd

Marksans Pharma Share Price

Pharmaceuticals
Mid Cap

-

0 (0%)


Start Investing in Marksans Pharma Ltd

*By signing up you agree to our Terms and Conditions

Marksans Pharma Ltd Performance

-

-

-

-


-

-

-

-

-

Marksans Pharma Ltd Fundamentals

13,112.29Cr

39.26

6.35

0.10

7.37

0.21%

45.57

i buttonClick here to know more about Fundamentals

Marksans Pharma Ltd Financials

Marksans Pharma Ltd Financialsright-arrow

Marksans Pharma Ltd Shareholding Pattern

Marksans Pharma Ltd Delivery and Volume

About Marksans Pharma Ltd

Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982. Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited with effect from 10th October, 2005. The Company primarily engaged in

Mark Saldanha

1992

MARKSANS

NameDesignation
Mark SaldanhaChairman & Managing Director
Harshavardhan PanigrahiCompany Sec. & Compli. Officer
Seetharama Raju BuddharajuNon-Exec. & Independent Dir.
Sandra SaldanhaWhole-time Director
Digant Mahesh ParikhNon-Exec. & Independent Dir.
Varddhman Vikramaditya JainWhole-time Director
Abhinna Sundar MohantyNon-Exec. & Independent Dir.
Sunny SharmaNon Executive Director
Shailaja VardhanIndependent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Marksans Pharma Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Marksans Pharma Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Marksans Pharma Ltd's share price is ₹289.15 as of 2024-10-13.
Marksans Pharma Ltd's P/E ratio is 39.26 times as of 2024-10-13.
Marksans Pharma Ltd's most recent financial reports indicate a price-to-book ratio of 6.35, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Marksans Pharma Ltd's market capitalization is ₹13112.29 Cr as on 2024-10-13.
The current financial records of Marksans Pharma Ltd show a 11.46% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Marksans Pharma Ltd's most recent financial filings, the company has a total asset value of ₹922.71, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Marksans Pharma Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Marksans Pharma Ltd's 52-week high and low as of 2024-10-13 are ₹292.6 and ₹286.95, respectively.